121 related articles for article (PubMed ID: 1880444)
21. In vitro activity of a new broad-spectrum, beta-lactamase-stable oral cephalosporin, cefixime, in comparison with other drugs, against Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis and Streptococcus pneumoniae.
Stefani S; Pellegrino MB; D'Amico G; Privitera A; Privitera O; Maccarrone G; Russo G; Nicoletti G
Chemotherapy; 1992; 38(1):36-45. PubMed ID: 1618002
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of cefixime (CL284635) and other antimicrobial agents against Haemophilus isolates from pediatric patients.
Kumar A; Kelly KJ
Chemotherapy; 1988; 34(1):30-5. PubMed ID: 3258232
[TBL] [Abstract][Full Text] [Related]
23. Antibacterial activity of cefixime against Streptococcus pneumoniae, Streptococcus pyogenes, and Haemophilus influenzae in the presence of Moraxella (Branhamella) catarrhalis.
Yamada T; Yokota Y; Ikeda F; Mine Y; Kitada T
Chemotherapy; 1992; 38(1):28-35. PubMed ID: 1618001
[TBL] [Abstract][Full Text] [Related]
24. Cefixime. A review of its antibacterial activity. Pharmacokinetic properties and therapeutic potential.
Brogden RN; Campoli-Richards DM
Drugs; 1989 Oct; 38(4):524-50. PubMed ID: 2684593
[TBL] [Abstract][Full Text] [Related]
25. Comparative activity of cefixime and cefaclor in an in vitro model simulating human pharmacokinetics.
Nies BA
Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):558-61. PubMed ID: 2504600
[TBL] [Abstract][Full Text] [Related]
26. Treatment of sinus empyema in adults. A coordinated Nordic multicenter trial of cefixime vs. cefaclor.
Carenfelt C; Melen I; Odkvist L; Olsson O; Prellner K; Rudblad S; Savolainen S; Skaftason S; Sorri M; Synnerstad B
Acta Otolaryngol; 1990; 110(1-2):128-35. PubMed ID: 2201163
[TBL] [Abstract][Full Text] [Related]
27. [Cefixime. Microbiologic, kinetic and clinical profile].
Di Nola F; Arione R; Bramato C
Minerva Med; 1991 Oct; 82(10):633-56. PubMed ID: 1745375
[TBL] [Abstract][Full Text] [Related]
28. [Potential pathogenic throat bacterial flora in acute successive pharyngitis and tonsillitis in children].
Chylak J
Med Dosw Mikrobiol; 1995; 47(1-2):25-33. PubMed ID: 8523968
[TBL] [Abstract][Full Text] [Related]
29. [In vitro effect of cefixime against Haemophilus influenzae].
Dabernat H; Delmas C
Presse Med; 1989 Oct; 18(32):1551-2. PubMed ID: 2530529
[TBL] [Abstract][Full Text] [Related]
30. Cefixime: spectrum of antibacterial activity against 16,016 clinical isolates.
Barry AL; Jones RN
Pediatr Infect Dis J; 1987 Oct; 6(10):954-7. PubMed ID: 3696835
[TBL] [Abstract][Full Text] [Related]
31. Cefaclor in the treatment of susceptible infections in infants and children.
Rodriguez WJ; Ross S; Schwartz R; Goldenberg R; Khan W
Postgrad Med J; 1979; 55 Suppl 4():35-8. PubMed ID: 548941
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of cefixime versus cefaclor in respiratory tract infections.
Dorow P
J Chemother; 1989 Aug; 1(4):257-60. PubMed ID: 2809693
[TBL] [Abstract][Full Text] [Related]
33. Comparative study of the effectiveness of cefixime and penicillin V for the treatment of streptococcal pharyngitis in children and adolescents.
Block SL; Hedrick JA; Tyler RD
Pediatr Infect Dis J; 1992 Nov; 11(11):919-25. PubMed ID: 1454432
[TBL] [Abstract][Full Text] [Related]
34. [5-day therapy of bacterial pharyngitis and tonsillitis with cefixime. Comparison with 10 day treatment with penicillin V. Cefixime Study Group].
Adam D; Hostalek U; Tröster K
Klin Padiatr; 1996; 208(5):310-3. PubMed ID: 8992100
[TBL] [Abstract][Full Text] [Related]
35. Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistance.
Cullmann W; Dick W; Stieglitz M; Opferkuch W
Chemotherapy; 1988; 34(3):202-15. PubMed ID: 3262045
[TBL] [Abstract][Full Text] [Related]
36. [Cefaclor versus penicillin V in staphylococcal infections in children].
Cohen R; de La Rocque F; Boucherat M; Lecompte MD; Bouhanna A; Wollner A; Ponet D; Elbez A; Richoux F; Brami A
Ann Pediatr (Paris); 1991 Apr; 38(4):289-95. PubMed ID: 1906258
[TBL] [Abstract][Full Text] [Related]
37. [Distribution and drug resistance of the isolated bacteria from children with acute respiratory infection].
Guo J; Cui ZZ; Huang Y; Yu AM
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):579-82. PubMed ID: 18947473
[TBL] [Abstract][Full Text] [Related]
38. [Fundamental and clinical studies on cefixime (5% granules) in the pediatric field].
Toyonaga Y; Sugita M; Nakamura H; Joh K; Takahashi T; Kurosu Y; Hori M
Jpn J Antibiot; 1986 Apr; 39(4):1055-75. PubMed ID: 3761537
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the effect of benzathine penicillin G, clarithromycin, cefprozil and amoxicillin/clavulanate on the bacteriological response and throat flora in group A beta hemolytic streptococcal tonsillopharyngitis.
Yildirim I; Ceyhan M; Gür D; Kaymakoğlu I
Turk J Pediatr; 2008; 50(2):120-5. PubMed ID: 18664074
[TBL] [Abstract][Full Text] [Related]
40. [5 days Cefaclor vs. 10 days amoxicillin/clavulanate in the treatment of childhood streptococcal pharyngitis. Data from a randomized clinical trial].
Bottaro G; Biasci P; Lo Giudice M; Mele G; Montanari G; Napoleone E; Santucci A; Tucci PL; Fano M; Biraghi MG
Minerva Pediatr; 2012 Jun; 64(3):341-6. PubMed ID: 22555328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
